The use of phage display to generate conformation-sensor recombinant antibodies

Nature Protocols

Volumn 7, Issue 12, 2012, Pages 2127-2143

  Haque, Aftabul ^a,b,c   Tonks, Nicholas K ^b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PROTEIN TYROSINE PHOSPHATASE 1B; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ARTICLE; BIOTINYLATION; CONFORMATIONAL TRANSITION; IMMUNE RESPONSE; ISOLATION PROCEDURE; MOLECULAR CLONING; OXIDATION REDUCTION POTENTIAL; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; PROTEIN STABILITY; SCREENING TEST; SENSOR; SOLID PHASE SYNTHESIS;

CELL SURFACE DISPLAY TECHNIQUES; EPITOPES; IMMUNOLOGIC TECHNIQUES; OXIDATION-REDUCTION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RECOMBINANT PROTEINS; SINGLE-CHAIN ANTIBODIES;

ANIMALIA;

EID: 84871155945     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2012.132     Document Type: Article

References (73)

1. Barbas, C.F., Kang, A.S., Lerner, R.A. & Benkovic, S.J. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc. Natl. Acad. Sci. USA 88, 7978-7982 (1991 (Pubitemid 21915278)
2. Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Making antibody fragments using phage display libraries. Nature 352, 624-628 (1991 (Pubitemid 21912394)
3. Griffiths, A.D. et al. Isolation of high-affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245-3260 (1994 (Pubitemid 24226939)
4. Hoogenboom, H.R. et al. Antibody phage display technology and its applications. Immunotechnology 4, 1-20 (1998 (Pubitemid 28302180)
5. McCafferty, J., Griffiths, A.D., Winter, G. & Chiswell, D.J. Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 348, 552-554 (1990 (Pubitemid 120015109)
6. Miersch, S. & Sidhu, S.S. Synthetic antibodies: Concepts, potential and practical considerations. Methods 57, 486-498 (2012
7. Hoogenboom, H.R. & Winter, G. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol. 227, 381-388 (1992
8. Winter, G., Griffiths, A.D., Hawkins, R.E. & Hoogenboom, H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455 (1994
9. Smothers, J.F., Henikoff, S. & Carter, P. Affinity selection from biological libraries. Science 298, 621-622 (2002 (Pubitemid 35215319)
10. Hoogenboom, H.R. & Chames, P. Natural and designer binding sites made by phage display technology. Immunol. Today 21, 371-378 (2000 (Pubitemid 30612297)
11. Burton, D.R. in Phage Display: A Laboratory Manual (eds. Barbas, C.F., Burton, D.R., Scott, J.K. & Silverman, G.J.) 3.1-3.18 (Cold Spring Harbor Laboratory, 2001
12. Bradbury, A.R., Sidhu, S., Dubel, S. & McCafferty, J. Beyond natural antibodies: The power of in vitro display technologies. Nat. Biotechnol. 29, 245-254 (2011
13. Bird, R.E. et al. Single-chain antigen-binding proteins. Science 242, 423-426 (1988
14. Willats, W.G. Phage display: Practicalities and prospects. Plant Mol. Biol. 50, 837-854 (2002 (Pubitemid 36034980)
15. Skerra, A. Bacterial expression of immunoglobulin fragments. Curr. Opin. Immunol. 5, 256-262 (1993 (Pubitemid 23125302)
16. Holt, L.J., Enever, C., de Wildt, R.M. & Tomlinson, I.M. The use of recombinant antibodies in proteomics. Curr. Opin. Biotechnol. 11, 445-449 (2000
17. Deshane, J. et al. Targeted tumor killing via an intracellular antibody against erbB-2. J. Clin. Invest. 96, 2980-2989 (1995
18. Jendreyko, N., Popkov, M., Rader, C. & Barbas, C.F. Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 102, 8293-8298 (2005 (Pubitemid 40800082)
19. Lynch, S.M., Zhou, C. & Messer, A. An scFv intrabody against the nonamyloid component of α-synuclein reduces intracellular aggregation and toxicity. J. Mol. Biol. 377, 136-147 (2008
20. Marasco, W.A., Haseltine, W.A. & Chen, S.Y. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90, 7889-7893 (1993 (Pubitemid 23250056)
21. Nizak, C. et al. Recombinant antibodies to the small GTPase Rab6 as conformation sensors. Science 300, 984-987 (2003 (Pubitemid 36548886)
22. Popkov, M., Jendreyko, N., McGavern, D.B., Rader, C. & Barbas, C.F. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. Cancer Res. 65, 972-981 (2005 (Pubitemid 40216459)
23. Ruberti, F. et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J. Neurosci. 20, 2589-2601 (2000 (Pubitemid 30220346)
24. Visintin, M., Quondam, M. & Cattaneo, A. The intracellular antibody capture technology: Towards the high-throughput selection of functional intracellular antibodies for target validation. Methods 34, 200-214 (2004 (Pubitemid 39092814)
25. Yuan, B. & Sierks, M.R. Intracellular targeting and clearance of oligomeric α-synuclein alleviates toxicity in mammalian cells. Neurosci. Lett. 459, 16-18 (2009
26. Haque, A., Andersen, J.N., Salmeen, A., Barford, D. & Tonks, N.K. Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity. Cell 147, 185-198 (2011
27. Tonks, N.K., Diltz, C.D. & Fischer, E.H. Purification of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem. 263, 6722-6730 (1988
28. Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548 (1999
29. Zabolotny, J.M. et al. Impaired insulin signaling and glucose uptake in muscle of muscle-specific PTP1B overexpressing mice. Diabetes 51, A330 (2002
30. Tonks, N.K. PTP1B: From the sidelines to the front lines! FEBS Lett. 546, 140-148 (2003 (Pubitemid 36782295)
31. Goldstein, B.J. Protein-tyrosine phosphatase 1B (PTP1B): A novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1, 265-275 (2001
32. Bence, K.K. et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 12, 917-924 (2006 (Pubitemid 44175143)
33. Iversen, L.F. et al. Structure determination of T cell protein-tyrosine phosphatase. J. Biol. Chem. 277, 19982-19990 (2002 (Pubitemid 34967521)
34. Andersen, J.N. et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell Biol. 21, 7117-7136 (2001 (Pubitemid 32953467)
35. Johnson, T.O., Ermolieff, J. & Jirousek, M.R. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat. Rev. Drug Discov. 1, 696-709 (2002 (Pubitemid 37368828)
36. Meng, T.C., Fukada, T. & Tonks, N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387-399 (2002 (Pubitemid 34195563)
37. Tonks, N.K. Redox redux: Revisiting PTPs and the control of cell signaling. Cell 121, 667-670 (2005 (Pubitemid 40797589)
38. Mahadev, K., Zilbering, A., Zhu, L. & Goldstein, B.J. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276, 21938-21942 (2001
39. Meng, T.C., Buckley, D.A., Galic, S., Tiganis, T. & Tonks, N.K. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J. Biol. Chem. 279, 37716-37725 (2004 (Pubitemid 39195485)
40. Salmeen, A. et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423, 769-773 (2003 (Pubitemid 36735701)
41. Van Montfort, R.L.M., Congreve, M., Tisi, D., Carr, R. & Jhoti, H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423, 773-777 (2003 (Pubitemid 36735702)
42. Nizak, C., Sandrine, M., Goud, B. & Perez, F. Selection and application of recombinant antibodies as sensors of Rab protein conformation. Methods Enzymol. 403, 135-153 (2005 (Pubitemid 43216904)
43. Gao, J., Sidhu, S.S. & Wells, J.A. Two-state selection of conformation-specific antibodies. Proc. Natl. Acad. Sci. USA 106, 3071-3076 (2009
44. Eisenhardt, S.U., Schwarz, M., Bassler, N. & Peter, K. Subtractive single-chain antibody (scFv) phage-display: Tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat. Protoc. 2, 3063-3073 (2007
45. Frangioni, J.V., Beahm, P.H., Shifrin, V., Jost, C.A. & Neel, B.G. The nontransmembrane tyrosine phosphatase Ptp-1B localizes to the endoplasmic-reticulum via Its 35 amino-acid C-terminal sequence. Cell 68, 545-560 (1992
46. Scholle, M.D., Collart, F.R. & Kay, B.K. In vivo biotinylated proteins as targets for phage-display selection experiments. Protein Expr. Purif. 37, 243-252 (2004 (Pubitemid 39027267)
47. Cloutier, S.M. et al. Streptabody, a high-avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Mol. Immunol. 37, 1067-1077 (2000 (Pubitemid 32786719)
48. Schatz, P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (NY) 11, 1138-1143 (1993 (Pubitemid 23307458)
49. Karisch, R. et al. Global proteomic assessment of the classical protein-tyrosine phosphatome and ″Redoxome″. Cell 146, 826-840 (2011
50. Capasso, M. et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat. Immunol. 11, 265-272 (2010
51. Crump, K.E., Juneau, D.G., Poole, L.B., Haas, K.M. & Grayson, J.M. The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur. J. Immunol. 42, 2152-2164 (2012
52. Boivin, B., Zhang, S., Arbiser, J.L., Zhang, Z.Y. & Tonks, N.K. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells. Proc. Natl. Acad. Sci. USA 105, 9959-9964 (2008
53. Liu, S. et al. Aryl vinyl sulfonates and sulfones as active site-directed and mechanism-based probes for protein tyrosine phosphatases. J. Am. Chem. Soc. 130, 8251-8260 (2008 (Pubitemid 351898544)
54. Kumar, S. et al. Activity-based probes for protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 101, 7943-7948 (2004 (Pubitemid 38698033)
55. Yang, J. et al. Reversible oxidation of the membrane distal domain of receptor PTPα is mediated by a cyclic sulfenamide. Biochemistry 46, 709-719 (2007 (Pubitemid 46137775)
56. Huse, M. & Kuriyan, J. The conformational plasticity of protein kinases. Cell 109, 275-282 (2002 (Pubitemid 34606870)
57. Kobe, B. & Kemp, B.E. Active site-directed protein regulation. Nature 402, 373-376 (1999 (Pubitemid 129544817)
58. Barford, D., Keller, J.C., Flint, A.J. & Tonks, N.K. Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. J. Mol. Biol. 239, 726-730 (1994 (Pubitemid 24202395)
59. Burton, D.R. et al. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88, 10134-10137 (1991 (Pubitemid 21915789)
60. Andris-Widhopf, J., Rader, C., Steinberger, P., Fuller, R. & Barbas, C.F. Methods for the generation of chicken monoclonal antibody fragments by phage display. J. Immunol. Methods 242, 159-181 (2000
61. Davies, E.L. et al. Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes. J. Immunol. Methods 186, 125-135 (1995
62. Barbas, C.F., Burton, D.R., Scott, J.K. & Silverman, G.J. Phage Display: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 2001
63. Huston, J.S. et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85, 5879-5883 (1988
64. Huston, J.S. & Haber, E. An overview of the 1996 Keystone meeting. Exploring and exploiting antibody and Ig superfamily combining sites. Immunotechnology 2, 253-260 (1996 (Pubitemid 27037859)
65. McGuinness, B.T. et al. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nat. Biotechnol. 14, 1149-1154 (1996 (Pubitemid 26299118)
66. Hoogenboom, H.R. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116 (2005 (Pubitemid 41486392)
67. Baneyx, F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10, 411-421 (1999 (Pubitemid 29457264)
68. Guglielmi, L. & Martineau, P. Expression of single-chain Fv fragments in E. coli cytoplasm. Methods Mol. Biol. 562, 215-224 (2009
69. Meng, T.C., Hsu, S.F. & Tonks, N.K. Development of a modified in-gel assay to identify protein tyrosine phosphatases that are oxidized and inactivated in vivo. Methods 35, 28-36 (2005 (Pubitemid 39647576)
70. Tonks, N.K., Diltz, C.D. & Fischer, E.H. Purification of protein-tyrosine phosphatases from human placenta. Methods Enzymol. 201, 427-442 (1991
71. Meng, T.C. & Tonks, N.K. Analysis of the regulation of protein tyrosine phosphatases in vivo by reversible oxidation. Methods Enzymol. 366, 304-318 (2003 (Pubitemid 37498379)
72. Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10881-10890 (1988
73. Tonks, N.K. Protein tyrosine phosphatases: From genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7, 833-846 (2006). (Pubitemid 44627477)